clipboard steeple boxes gift circle-arrow chevron-thin-right chevron-thin-left magnify alasu instagram youtube feed twitter facebook

Welcome to Alabama State University. The following assistives navigation will help you jump to specific areas of the page.


Dr. Robertson.jpg

Dr. B. K. Robertson, Chairman

Bio-Safety Committee

 Montgomery, Alabama


The Alabama State University Institutional Biosafety Committee was established to assure appropriate handling of potentially hazardous biological materials, to reduce the risk of exposure to those materials (i.e. infectious agents, rDNA, biological toxins, and other selected agents, and to prevent the release of biohazardous materials into the environment.

The current members of the IBC include Dr. Eddie Moore, Ms Yvonne Williams, Dr. Karyn Scissum-Gunn, Dr. Kennedy Wekesa, and Dr. B.K. Robertson as its Chairperson.

Application for approval is required for all research activities involving the use or manipulation of infectious agents (including but not limited to bacteria, viruses, fungi, rickettsia, protozoa, or parasites), biological toxins, select agents, toxins, and/or recombinant deoxyribonucleic acid (rDNA). It is the policy of the IBC that the Principal Investigators (PI) is responsible for proper acquisition, use, handling, storage transportation, and disposal of biohazardous materials in research. All individuals working with these materials must adhere to the procedures, and rules. ASU IBC review and approval is required prior to using the following biohazardous agents:

a. The use of recombinant DNA as defined by the NIH Guidelines published by the center for Disease Control and Prevention (CDC).

 b. Any microorganism (including but not limited to bacteria, viruses, fungi, rickettsia, protozoa, or parasites), or infectious substance, or naturally occurring, bioengineered, or synthesized component of any such microorganism or infectious substance that is capable of causing death, disease, or other biological malfunction in a human, an animal, or plant.

The IBC policy is being drafted in accordance with the following regulations and guidelines:
a. NIH Guidelines for Research Involving Recombinant DNA molecules. The NIH Guidelines publication is available at
b. Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5TH edition, published by the CDC.

Committee Members

Dr. Eddie Moore, Professor of Microbiology

Dr. Kennedy Wekesa, Professor of Biology

Dr.Karyn Scissum-Gunn, Provost, Academic Affairs

Ms. Yvonne Williams, HBCU-UP/CREST, Assistant Director 

Contact Information

Dr. B. K. Robertson, Chairman

Life Science Building Room 231

Phone: (334) 229-4423



Back to top